CMN Weekly (20 December 2024) - Your Weekly CRISPR...
CMN Weekly
Dec. 20, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Altos Labs
Company Type: Therapeutic development
Main focus: Harnessing cellular rejuvenation to reverse disease and extend human healthspan
Company stage: Pre-clinical
Diseases: Aging and age-related diseases
Genome-editing tool:
Funding stage: Series A
Location: Redwood City, California, USA
Website: https://www.altoslabs.com/
Pipeline: not disclosed
Partners: not disclosed
Altos Labs™ (Altos™) is a biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. The company comprises a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission. Altos has operations in the San Francisco Bay Area and San Diego, and in Cambridge, UK, with significant collaborations in Japan.
